A new report in the June issue of Clinical Cancer Research, says that antiestrogen drug hormone therapy given to women with ovarian cancer can extend their life expectancy. The UK-funded study of 44 women offers a first alternative to chemotherapy.
Related posts:
- Estrogen Therapy May Benefit Younger Women
- Cancer Care Inequality
- Is Red Wine the New Anti-Aging Drug?
- Tykerb: A New Cancer Drug Approved
- Prevalent Women’s Health Condition Affects 1 Out of Every 5 Women
|
Comments








